Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-26 @ 6:25 PM
Study NCT ID:
NCT00147160
Status:
COMPLETED
Last Update Posted:
2012-04-11
First Post:
2005-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
2006-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-06
First Submit QC Date:
None
Study First Post Date:
2005-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-04-10
Last Update Post Date:
2012-04-11
Last Update Post Date Type:
ESTIMATED